GRACECast - LCVL - Could pre-operative immunotherapy improve outcomes in early stage NSCLC episode artwork

EPISODE · Feb 3, 2021 · 9 MIN

GRACECast - LCVL - Could pre-operative immunotherapy improve outcomes in early stage NSCLC

from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE

Dr. Joel Neal discusses pre-operative immunotherapy and if it could improve outcomes in early stage NSCLC. Why trials are looking at this approach.

Episode metadata supplied by the publisher feed · Published Feb 3, 2021

Embed this episode

NOW PLAYING

GRACECast - LCVL - Could pre-operative immunotherapy improve outcomes in early stage NSCLC

0:00 9:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of GRACEcast - Discussions with the Global Resource for Advancing Cancer Education?

This episode is 9 minutes long.

When was this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode published?

This episode was published on February 3, 2021.

Can I download this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!